Teva Pharmaceutical Industries Ltd (ADR) Share Price Nasdaq
Equities
US8816242098
Pharmaceuticals
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.57 USD | 0.00% | 0.00% | 0.00% |
Sales 2024 * | 15.95B 1,255B | Sales 2025 * | 16.52B 1,300B | Capitalization | 18.79B 1,479B |
---|---|---|---|---|---|
Net income 2024 * | 820M 64.54B | Net income 2025 * | 1.39B 109B | EV / Sales 2024 * | 2.11 x |
Net Debt 2024 * | 14.93B 1,175B | Net Debt 2025 * | 12.41B 977B | EV / Sales 2025 * | 1.89 x |
P/E ratio 2024 * |
17.6
x | P/E ratio 2025 * |
12.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.44% |
Latest transcript on Teva Pharmaceutical Industries Ltd (ADR)
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 31/12/22 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 21/12/19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 31/08/15 |
Janet Vergis
BRD | Director/Board Member | 59 | 08/06/20 |
Sol Barer
CHM | Chairman | 76 | 31/12/14 |
1st Jan change | Capi. | |
---|---|---|
+37.78% | 723B | |
+30.93% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.23% | 244B | |
-4.87% | 208B | |
+9.93% | 210B | |
+9.32% | 169B |